Longeveron (LGVN) Other Operating Expenses (2020 - 2024)
Longeveron (LGVN) recorded quarterly Other Operating Expenses of -$100000.0 in Q3 2024, little changed quarter-over-quarter from -$100000.0 in Q2 2024, and down 281.82% on a YoY basis from $55000.0 in Q4 2023.
Longeveron (LGVN) Other Operating Expenses (2020 - 2024) Analysis & Trends
Longeveron's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$100000.0 for Q3 2024.
- In Q3 2024, Other Operating Expenses fell 281.82% year-over-year to -$100000.0; the TTM figure through Jun 2025 stood at -$100000.0 (down 122.22% YoY), while the FY2025 annual figure was -$97000.0, changed N/A from the prior year.
- Other Operating Expenses was -$100000.0 for Q3 2024 at Longeveron, roughly flat from -$100000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.1 million in Q4 2021 to a low of -$1.4 million in Q2 2022.
- Historically, Other Operating Expenses has averaged $59812.5 across 5 years, with a median of $51500.0 in 2020.
- The sharpest annual moves came in 2021 and 2022: Other Operating Expenses jumped 1733.9% in 2021, then slumped 2747.17% in 2022.
- A 5-year view of Other Operating Expenses shows it stood at $59000.0 in 2020, then surged by 1733.9% to $1.1 million in 2021, then plunged by 73.66% to $285000.0 in 2022, then tumbled by 80.7% to $55000.0 in 2023, then slumped by 281.82% to -$100000.0 in 2024.
- The last three Other Operating Expenses figures came in at -$100000.0 (Q3 2024), -$100000.0 (Q2 2024), and $55000.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Dec 31, 2022 | 285,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | 287,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 53,000.00 |
| Mar 31, 2021 | 550,000.00 |
| Dec 31, 2020 | 59,000.00 |
| Sep 30, 2020 | 44,000.00 |
| Jun 30, 2020 | 47,000.00 |
| Mar 31, 2020 | 50,000.00 |